drugs
|
specialties
|
education
UnregisterUser
Download App
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Download App
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
education
UnregisterUser
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Keppra
Keppra
levetiracetam
Manufacturer:
GlaxoSmithKline Indonesia
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Description
Action
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
Storage
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive treatment of partial onset of seizures w/ or w/o secondary generalisation in patient w/ epilepsy.
Click to view Keppra detailed prescribing information
Dosage/Direction for Use
Daily dose is administered in 2 equally divided doses.
Adult & adolescent ≥16 yr
Initially 500 mg twice daily, may be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2-4 wkly.
Click to view Keppra detailed prescribing information
Overdosage
View
Keppra overdosage
for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to levetiracetam or other pyrrolidones derivatives.
Click to view Keppra detailed prescribing information
Special Precautions
Abrupt discontinuation. Renal & severe hepatic impairment. May affect ability to drive or operate machinery. Pregnancy & lactation. Elderly.
Click to view Keppra detailed prescribing information
Use In Pregnancy & Lactation
Click to view Keppra detailed prescribing information
Adverse Reactions
Asthenia; somnolence; headache, dizziness, tremor; depression, insomnia, nervousness; diarrhoea, dyspepsia, nausea; anorexia; vertigo; diplopia; accidental injury.
Click to view Keppra detailed prescribing information
Storage
View
Keppra storage
conditions for details to ensure optimal shelf-life.
Description
View
Keppra description
for details of the chemical structure and excipients (inactive components).
Action
View
Keppra mechanism of action
for pharmacodynamics and pharmacokinetics details.
MIMS Class
Anticonvulsants
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Regulatory Classification
G
Presentation/Packing
Form
Keppra FC tab 250 mg
Packing/Price
30's
Form
Keppra FC tab 500 mg
Packing/Price
20's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member?
Sign in